UBS Group’s Constellium CSTM Stock Holding History

UBS Group’s Portfolio CSTM Stock Details CSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-25,000	Closed	-$499K	–	9408
2023 Q4	$499K	Sell	25,000 -71,100	-74%	-$1.24M	﹤0.01%	5110
2023 Q3	$1.75M	Buy	+96,100	New	+$1.69M	﹤0.01%	3568
2022 Q1	–	Sell	-50,000	Closed	-$896K	–	10338
2021 Q4	$896K	Buy	+50,000	New	+$918K	﹤0.01%	4487
2021 Q3	–	Sell	-10,000	Closed	-$190K	–	9610
2021 Q2	$190K	Buy	+10,000	New	+$172K	﹤0.01%	5387
2021 Q1	–	Sell	-3,600	Closed	-$50K	–	9052
2020 Q4	$50K	Buy	+3,600	New	+$40.7K	﹤0.01%	6181
2020 Q3	–	Sell	-59,000	Closed	-$453K	–	8043
2020 Q2	$453K	Buy	+59,000	New	+$429K	﹤0.01%	4225
2019 Q4	–	Sell	-180,000	Closed	-$2.29M	–	8142
2019 Q3	$2.29M	Buy	+180,000	New	+$2.12M	﹤0.01%	3163

Other funds holding CSTM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bpifrance Maisons Alfort, Cedex, France $1.36B AUM 21.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

UBS Group's CSTM Position: Q1 2026 in Review

UBS Group reduced its Constellium (CSTM) stake by 15% in Q1 2026, selling an estimated $1.98M and leaving 471,495 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #3178.

UBS Group first reported a position in CSTM in Q4 2014 and has held it in 46 quarters since. 313 funds tracked by Wall St. Rank hold CSTM as of Q1 2026.

UBS Group held 471,495 shares of Constellium worth $11.6M as of Q1 2026.
UBS Group sold 83,405 Constellium shares in Q1 2026, an estimated $1.98M.
Constellium made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #3178 holding.
UBS Group first reported a position in Constellium in Q4 2014 and has held it in 46 quarters since.
313 funds tracked by Wall St. Rank held Constellium as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.